{"title":"肢端肥大症患者的长效促生长激素类似物治疗：何时以及如何治疗。","authors":"Luigi Simone Aversa, Michela Sibilla, Nunzia Prencipe, Valentina Gasco, Ezio Ghigo, Silvia Grottoli","doi":"10.1159/000539990","DOIUrl":null,"url":null,"abstract":"<p><p>Somatostatin and its analogs have been for years a mainstay treatment for a variety of hypersecretory conditions and neoplasms of the endocrine system. This chapter summarizes their pharmacological properties, their indication in the context of acromegaly, and the best way to handle this class of drugs for the treatment of the patient with acromegaly.</p>","PeriodicalId":520300,"journal":{"name":"Frontiers of hormone research","volume":"55 ","pages":"182-200"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Treatment with Long-Acting Somatostatin Analogues in Patients with Acromegaly: When and How.\",\"authors\":\"Luigi Simone Aversa, Michela Sibilla, Nunzia Prencipe, Valentina Gasco, Ezio Ghigo, Silvia Grottoli\",\"doi\":\"10.1159/000539990\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Somatostatin and its analogs have been for years a mainstay treatment for a variety of hypersecretory conditions and neoplasms of the endocrine system. This chapter summarizes their pharmacological properties, their indication in the context of acromegaly, and the best way to handle this class of drugs for the treatment of the patient with acromegaly.</p>\",\"PeriodicalId\":520300,\"journal\":{\"name\":\"Frontiers of hormone research\",\"volume\":\"55 \",\"pages\":\"182-200\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers of hormone research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1159/000539990\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers of hormone research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000539990","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Treatment with Long-Acting Somatostatin Analogues in Patients with Acromegaly: When and How.
Somatostatin and its analogs have been for years a mainstay treatment for a variety of hypersecretory conditions and neoplasms of the endocrine system. This chapter summarizes their pharmacological properties, their indication in the context of acromegaly, and the best way to handle this class of drugs for the treatment of the patient with acromegaly.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
